Cardiff Oncology, Inc. (CRDF): Total Assets
$61.88M
As of 2025-12-31
$37.33M
As of 2026-06-30
-18.9%
3-year compound annual growth
-14.4%
5-year compound annual growth
-1.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $61.88M | -36.3% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $97.19M | +19.1% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $81.64M | -29.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $116.19M | -22.3% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $149.54M | +11.0% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $134.73M | +929.5% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $13.09M | -7.7% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $14.17M | +15.4% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $12.28M | -72.0% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $43.95M | -38.5% | 2018-02-26, Balance as of period end |
| 2015-12-31 | $71.45M | +147.2% | 2017-03-15, Balance as of period end |
| 2014-12-31 | $28.90M | +6.4% | 2016-03-10, Balance as of period end |
| 2013-12-31 | $27.16M | +132.8% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $11.67M | n/m | 2014-03-17, Balance as of period end |
| 2011-12-31 | $1.04M | n/a | 2013-04-01, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $61.88M | -36.3% |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $152.98M | +860.8% |
| Prokidney Corp. (PROK) | 2025-12-31 | $335.57M | -23.9% |
| Pluri Inc. (PLUR) | 2026-06-30 | $24.88M | -35.7% |
| Inhibrx Biosciences, Inc. (INBX) | 2025-12-31 | $146.48M | -19.0% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | $11.63M | -13.5% |
| Outlook Therapeutics, Inc. (OTLK) | 2025-09-30 | $18.58M | -35.5% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $93.00M | -4.0% |
| Humacyte, Inc. (HUMA) | 2025-12-31 | $116.37M | -15.6% |
Compare CRDF, IMA, PROK, PLUR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗